X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1178) 1178
Publication (108) 108
Newsletter (89) 89
Book Chapter (15) 15
Book Review (15) 15
Dissertation (3) 3
Book / eBook (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (906) 906
male (498) 498
hyperaldosteronism (496) 496
female (483) 483
index medicus (482) 482
hypertension (449) 449
middle aged (365) 365
adult (328) 328
endocrinology & metabolism (303) 303
aldosterone (273) 273
diagnosis (251) 251
primary aldosteronism (247) 247
hyperaldosteronism - genetics (230) 230
hyperaldosteronism - diagnosis (218) 218
hyperaldosteronism - complications (211) 211
aldosterone - blood (208) 208
hyperaldosteronism - metabolism (176) 176
research (169) 169
prevalence (167) 167
animals (162) 162
peripheral vascular disease (159) 159
renin - blood (159) 159
aged (158) 158
hyperaldosteronism - physiopathology (158) 158
hypertension - etiology (149) 149
primary hyperaldosteronism (145) 145
hyperaldosteronism - blood (139) 139
hyperaldosteronism - etiology (134) 134
adrenalectomy (133) 133
mutation (123) 123
blood pressure (110) 110
hypertension - physiopathology (110) 110
risk factors (110) 110
blood-pressure (109) 109
abridged index medicus (103) 103
aldosterone - metabolism (100) 100
care and treatment (100) 100
glucocorticoid-remediable aldosteronism (97) 97
corticosteroids (96) 96
genetic aspects (95) 95
adenoma (93) 93
hyperaldosteronism - surgery (89) 89
hyperaldosteronism - drug therapy (88) 88
expression (86) 86
medicine, general & internal (85) 85
hyperaldosteronism - pathology (84) 84
somatic mutations (76) 76
hypertension - blood (75) 75
tumors (75) 75
hypertension - genetics (73) 73
cytochrome p-450 cyp11b2 - genetics (70) 70
g protein-coupled inwardly-rectifying potassium channels - genetics (70) 70
hypertension - diagnosis (70) 70
renin (70) 70
physiological aspects (69) 69
aldosterone - secretion (68) 68
hypertension - drug therapy (68) 68
adrenal gland neoplasms - complications (66) 66
angiotensin-ii (66) 66
familial hyperaldosteronism (66) 66
retrospective studies (66) 66
adolescent (65) 65
health aspects (64) 64
aldosterone - biosynthesis (63) 63
urology & nephrology (63) 63
adenoma - complications (61) 61
hyperaldosteronism - therapy (61) 61
adrenal glands (59) 59
hyperaldosteronism - epidemiology (59) 59
hypertension - metabolism (59) 59
hypertension - complications (57) 57
hyperplasia (55) 55
mice (55) 55
adenomas (54) 54
diagnosis, differential (54) 54
kcnj5 mutations (54) 54
mutations (54) 54
secretion (53) 53
blood pressure - drug effects (52) 52
potassium - blood (52) 52
hyperaldosteronism type-ii (51) 51
phenotype (51) 51
physiology (51) 51
hypertensive patients (50) 50
medicine (50) 50
surgery (50) 50
treatment outcome (50) 50
adrenal cortex neoplasms - metabolism (49) 49
reports (49) 49
adrenal cortex neoplasms - genetics (48) 48
steroid 11-beta-hydroxylase - genetics (48) 48
adrenal gland neoplasms - surgery (46) 46
resistant hypertension (46) 46
adenoma - metabolism (45) 45
child (45) 45
dexamethasone (45) 45
spironolactone (43) 43
spironolactone - therapeutic use (43) 43
steroids (43) 43
antihypertensive agents - therapeutic use (42) 42
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1219) 1219
French (16) 16
German (12) 12
Italian (8) 8
Polish (7) 7
Russian (7) 7
Spanish (6) 6
Czech (2) 2
Hungarian (2) 2
Korean (2) 2
Chinese (1) 1
Dutch (1) 1
Japanese (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Endocrinology, ISSN 0300-0664, 09/2017, Volume 87, Issue 3, pp. 233 - 241
Journal Article
Journal of Hypertension, ISSN 0263-6352, 07/2019, Volume 37 Suppl 1, pp. e283 - e283
OBJECTIVE:Primary aldosteronism (PA), the most common cause of endocrine hypertension, is a disorder due to bilateral adrenal hyperplasia (BAH) and aldosterone... 
Receptors | Genetic aspects | Research | Hyperaldosteronism | Gene expression | Angiotensin
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 2017, Volume 87, Issue 3, p. 233
Context: Diabetes and hypertension coexist in 40%-60% of individuals with type 2 diabetes. The coexistence of these two conditions is associated with increased... 
Heart | Hyperaldosteronism | hypokalaemia | diabetes complications | Blood | Clinical-Practice Guideline | Hypertensive-Rats | Endokrinologi och diabetes | primary aldosteronism | Individuals | Diagnosis | Mineralocorticoid Receptor | diabetes mellitus type 2 | hypertension | Endocrinology and Diabetes | Mellitus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173581
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2016, Volume 101, Issue 11, pp. 4290 - 4297
Context: To date, all the familial hyperaldosteronism type III (FH-III) patients reported presenting with typical primary aldosteronism (PA), without showing... 
SUBTYPE | ENDOCRINOLOGY & METABOLISM | KCNJ5 MUTATIONS | MONOCLONAL-ANTIBODIES | HYPERTENSION | TUMORS | ADENOMAS | CORTISOL | Hyperaldosteronism - diagnosis | Young Adult | Phenotype | Humans | Cushing Syndrome - diagnosis | Adult | Male | Hyperaldosteronism - classification | Original
Journal Article
CLINICAL SCIENCE, ISSN 0143-5221, 03/2018, Volume 132, Issue 6, pp. 627 - 640
The angiotensin II (Ang II) type 2 receptor (AT2R) and the angiotensin-(1-7) (Ang-(1-7)) receptor (MasR) play a cardiovascular protective role by... 
MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | ACTIVATION | ADRENAL-CORTEX | AT RECEPTORS | BIOSYNTHESIS | HEART-FAILURE | GENE-EXPRESSION | SECRETION | AT2 RECEPTOR | II RECEPTORS | Receptors, G-Protein-Coupled - metabolism | Zona Glomerulosa - drug effects | Humans | Hyperaldosteronism - pathology | Zona Glomerulosa - pathology | Hyperaldosteronism - metabolism | Steroid 11-beta-Hydroxylase - genetics | Angiotensin II Type 1 Receptor Blockers - pharmacology | Case-Control Studies | Aldosterone - metabolism | Receptor, Angiotensin, Type 1 - genetics | Adrenocortical Adenoma - genetics | Adrenal Cortex Neoplasms - metabolism | Cytochrome P-450 CYP11B2 - metabolism | Proto-Oncogene Proteins - metabolism | Cell Line | Receptor, Angiotensin, Type 2 - agonists | Receptor, Angiotensin, Type 2 - genetics | Hyperaldosteronism - genetics | Thiophenes - pharmacology | Proto-Oncogene Proteins - genetics | Renin-Angiotensin System - genetics | Zona Glomerulosa - metabolism | Adrenal Cortex Neoplasms - pathology | Sulfonamides - pharmacology | Adrenocortical Adenoma - pathology | Adrenocortical Adenoma - metabolism | Adrenal Cortex Neoplasms - genetics | Receptor, Angiotensin, Type 2 - metabolism | Steroid 11-beta-Hydroxylase - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Renin-Angiotensin System - drug effects | Receptors, G-Protein-Coupled - genetics | Cytochrome P-450 CYP11B2 - genetics | Irbesartan - pharmacology
Journal Article